Competing interests
GB has received honoraria for lectures from Ferring, Ipsen, Lilly, Merck Serono, Novo Nordisk, Pfizer, and Sandoz and for membership in advisory boards from Ferring, Ipsen, Novo Nordisk, and Pfizer.
DS has received honoraria for lectures from Ipsen, Merck Serono, Novo Nordisk, Pfizer, and Sandoz and for membership in advisory boards from Novo Nordisk, Merck Serono, and Sandoz.
TR has received honoraria for lectures from Ipsen, Merck Serono, Novo Nordisk, Ferring, Lilly, Pfizer, and Sandoz and for membership in advisory boards from Novo Nordisk, Ferring, Merck Serono, and Sandoz.
RP has received honoraria for lectures from Sandoz, Ipsen, Novo Nordisk, Merck Serono, and Ferring and for membership in advisory boards from Sandoz, Novo Nordisk, and Lilly.
HGD has received honoraria for lectures from Ferring, Ipsen, Novo Nordisk, and Pfizer.
MB has received honoraria for lectures from Novo Nordisk, Pfizer, Ipsen, and Hexal and advisory fees from Takeda Pharmaceutical Company Limited.
BH has received honoraria for lectures from Boehringer, Ferring, Ipsen, Merck Serono, Novo Nordisk, Pfizer, and Sandoz and for membership in advisory boards from Merck Serono and Sandoz.
JW has received honoraria for lectures/presentations from Ipsen, Merck Serono, Novo Nordisk, and Pfizer and for membership in advisory boards from Ipsen and Novo Nordisk.